Author: admin

XIFEI Launches Personalized Cigar Cutters

Renowned for precision and innovation, XIFEI is thrilled to announce the release of its latest collection of premium cigar cutters. This lineup, crafted with elegance and functionality, meets the needs of modern cigar enthusiasts while delivering an unparalleled cutting experience. With a focus on sharpness, ease of use, and durability, these new products underscore XIFEI dedication to quality in the cigar accessory market.

The first of XIFEI new cutters showcases ultra-sharp stainless steel V-cut blades housed in a sturdy zinc alloy body, designed to handle cigars up to 58 ring gauge. This ergonomic tool features dual cigar punches and a compact form, making it the perfect accessory for any setting, from business gatherings to home use. Its combination of non-slip properties and precise engineering offers a consistently smooth, clean cut, giving cigar aficionados a dependable tool they can carry anywhere. The second model in the collection offers a luxurious 3-in-1 design, combining a stainless steel V-cutter, a cigar punch, and a cigar holder all in one. With an ergonomic, one-handed operation, this cutter effortlessly accommodates cigars up to 55 ring gauge. The zinc alloy body not only ensures durability but adds a touch of sophistication, making it an ideal gift choice. This multitool’s compact size and built-in holder offer convenience, enhancing the cigar experience for both seasoned and new smokers.

The final model is tailored for cigar lovers seeking simplicity and functionality. Designed for one-handed operation, this cutter features an auto-opening mechanism and a precision-engineered V-cut blade that makes clean cuts on cigars of various sizes. Packaged in an elegant gift box, it’s the perfect accessory for holidays or special occasions, seamlessly combining ease of use with refined design.

XIFEI is dedicated to enhancing the cigar experience with high-quality accessories that merge craftsmanship with contemporary design. With a lineup that includes lighters, cutters, and humidors, XIFEI provides products that meet the high standards of cigar enthusiasts worldwide. From design to production, XIFEI emphasizes precision, functionality, and style in every product, ensuring that each accessory is a trusted companion in the cigar journey.

For more information on XIFEI cigar cutters and other premium cigar accessories, please visit: https://shorturl.at/FcbdN, https://shorturl.at/iwEPG, https://shorturl.at/emNor, https://shorturl.at/wSArZ

Media Contact
Company Name: East Association Surplus Trade Co., Ltd. – Fei XI
Email: Send Email
Phone: +86 18126003429
Country: China
Website: https://shorturl.at/a5Uc0

Upgaming Will Be Exhibiting at SiGMA Europe 2024

Upgaming is set to showcase its award-nominated sportsbook and aggregator software at SiGMA Europe 2024. Visit Stand N1165, November 11-14 in Malta

Enterprise iGaming software provider Upgaming will be exhibiting in SiGMA Europe 2024, one of the most important events in the iGaming industry. The event will be held in Malta from November 11 to 14, bringing together top professionals, innovators, and enthusiasts from around the world.

At SiGMA Europe, Upgaming will showcase its latest products and solutions. Among the highlights is Upgaming’s highly scalable sportsbook software with over 112,000 live events, +96 000 pre-match events,  and more than 5,300 markets. The software also has been shortlisted at SiGMA Europe Awards as the “Most Innovative Sportsbook Solution 2024”.

Moreover, Upgaming has also been shortlisted in the category of “Best Aggregator 2024” at SiGMA Europe awards, which brings as to another key product on display. Upgaming will showcase its Game Aggregation software, which became the winner of SiGMA Eurasia Awards 2023 and allows operators to integrate more than 12,000 games from over 180 top-tier providers. Additionally, Upgaming will present its Enterprise Platform, an all-in-one solution designed to streamline operations for large iGaming businesses. This platform includes comprehensive back-office management tools, a CRM system, a payment system, and strong security features.

Upgaming’s Mini Games will also be a focal point at the event. Known for their quick and engaging gameplay, these games are perfect for players looking for fast and fun gaming experiences. Attendees will have the opportunity to try popular mini games like Dino, Chicken, and Aero, as well as new titles such as Speed X, Chicken Cross, and Doors.

SiGMA Europe is a major event for the iGaming industry, offering an excellent opportunity to build relationships, learn about new trends, and grow your business. Upgaming invites all partners and interested parties to visit Stand N1165 to explore their innovative products and solutions firsthand. 

The Upgaming team will be available to demonstrate their offerings, discuss industry trends, and explore potential partnerships. Don’t miss the chance to see how Upgaming can elevate your gaming business to new heights.

About Upgaming

Upgaming is a leading iGaming solutions provider, offering exclusive products, including ultra-fast Sportsbook with scalable infrastructure, E-sports, live casino, casino and popular mini-games unified in an innovative, multifunctional, and customizable iGaming platform. We offer a mixture of iGaming software and products designed specifically to increase your customer’s loyalty and engagement. Committed to supplying our clients with the most convenient and user-friendly interface, we enrich our platform with modern AI technologies, API protocols, and data management tools.

Media Contact
Company Name: Upgaming AG
Contact Person: Harris Reynolds
Email: Send Email
Country: Switzerland
Website: http://upgaming.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Upgaming Will Be Exhibiting at SiGMA Europe 2024

Future Electronics Announces Digital Campaign in Asia Featuring 3 Innovative AI Solutions from Renesas

Future Electronics Announces Digital Campaign in Asia Featuring 3 Innovative AI Solutions from Renesas
Future Electronics is announcing a new digital campaign in Asia featuring 3 innovative AI solutions from Renesas.

Montreal, Canada – October 29, 2024 – Future Electronics, a leading global distributor of electronic components, is proud to announce the launch of its latest AI Solutions Campaign in Asia, featuring cutting-edge solutions from Renesas. This campaign highlights three innovative technologies from Renesas, designed to empower developers and engineers to seamlessly integrate AI into a wide range of applications.

Renesas, a global leader in microcontrollers, microprocessors, SoCs, analog and power products, is at the forefront of advancing AI technologies that simplify design challenges and enable high-performance solutions. Through this campaign, Future Electronics aims to showcase these key offerings:

Enabling Intelligence from the Cloud to the Edge and Endpoint Sustainably, Renesas’ comprehensive AI/ML developer stack enables a broad range of solutions including Real-time Analytics, Vision and Voice. Renesas covers all IoT layers with extensive portfolios in sensing, connectivity, computing, and actuation. The rich software, tools, solution offerings, and partner ecosystem provide the essential elements to accelerate customers’ AIoT designs.

– Real Time Analytics: Discover Reality AI, an Edge AI software environment, which integrates advanced signal processing, machine learning, and anomaly detection on Renesas MCU/MPU cores. The software is underpinned by the proprietary Reality AI ML algorithm that delivers accurate and fully explainable results supporting diverse applications. These include equipment monitoring, predictive maintenance, and sensing user behavior as well as the surrounding environment.

– AI Vision: Renesas provides a comprehensive range of Vision AI products, tools, and solutions to cater to developers of all skill levels. The high-performance Vision AI solutions, coupled with a scalable lineup of MCUs and MPUs, address a wide spectrum of AI applications aligned with diverse market needs. Leveraging the in-house AI accelerator DRP-AI and optimized CPU architecture, Renesas offers unparalleled power efficiency to tackle critical design challenges related to heat dissipation and power consumption. User-friendly developer tools and workflows, enriched with a vast library of pre-trained applications, expedite the initiation and acceleration of the projects, no matter the expertise level.

– AI Voice: In today’s rapidly evolving digital era, Voice User Interfaces (VUI) are reshaping user interactions with technology. Renesas offers advanced VUI solutions that harness cutting-edge semiconductor technology to deliver seamless, intuitive, and highly responsive voice experiences, elevating the standard for user engagement and satisfaction. Comprehensive development support including tools, software development kits and expert technical assistance to streamline the integration and optimization of VUI technology accelerates the product development cycle.

For more information, visit the campaign’s main hub page: www.FutureElectronics.com/resources/promotions/renesas202409?loc=3.

About Future Electronics

Founded in 1968, Future Electronics is a global leader in the electronic components industry. Future Electronics’ award-winning customer service, global supply chain programs and industry-leading engineering design services have made the company a strategic partner of choice.

Headquartered in Montreal, Canada, Future Electronics operates in 159 offices across 44 countries with over 5,000 employees. Its worldwide presence powers the company’s outstanding service and efficient, comprehensive global supply chain solutions. Future Electronics is globally integrated and supported by one IT infrastructure which provides real-time inventory availability and enables fully integrated operations, sales and marketing services worldwide. In 2024, Future became a WT Microelectronics company, now dual-headquartered in both Montreal, Canada and Taipei City, Taiwan.

Future Electronics’ mission is always to Delight the Customer®. For more information visit www.FutureElectronics.com.

Media Contact
Company Name: Future Electronics
Contact Person: Jamie Singerman
Email: Send Email
Phone: 514-694-7710
Address:237 Hymus Boulevard
City: Pointe Claire
State: Quebec
Country: Canada
Website: https://www.futureelectronics.com/

Elegant Image Limos Elevates Paso Robles Wine Tours with Custom Luxury Experiences

Central Coast transportation company redefines wine tours with personalized service and premium party buses.

Elegant Image Limos, a leading transportation company on California’s Central Coast, is proud to announce its exciting focus on curating exceptional Paso Robles Wine Tours for groups of all sizes. With a fleet of luxurious party buses, limousines, sedans, and SUVs, the company offers a new way to experience the renowned wineries of Paso Robles. By elevating transportation into a core part of the wine tour journey, Elegant Image Limos ensures unforgettable memories for every customer.

Unlike traditional tour operators that rely on basic shuttle buses, Elegant Image Limos tailors each tour to deliver elegance and comfort, creating an adventure from the moment guests board their vehicles. The company’s luxury party buses make the journey between wineries as exciting as the tastings themselves, bringing friends and families together to share the experience.

“Customer satisfaction is #1,” said a company representative. “We provide elegance in every ride and memories that last a lifetime.”

Crafting Memorable Paso Robles Wine Tours

Elegant Image Limos specializes in creating bespoke wine tours designed to match the unique preferences of each group. With over 500 wineries in the Paso Robles region, guests have endless options, from intimate tastings to large group tours. To enhance the experience, Elegant Image offers complimentary Champagne, bottled water, and soft drinks during every tour.

“Planning a wine tour should be as enjoyable as the tour itself,” explained the team. “Our staff helps organize routes, ensuring every tour is smooth and filled with stops that reflect the group’s tastes.”

Some of the most recommended wineries included in their itineraries are Tobin James, Epoch, Hammersky, Opolo Vineyards, and Daou Vineyards, among others. From breathtaking ocean and countryside views to expert planning, Elegant Image Limos delivers the finest Paso Robles wine tours available.

A recent customer shared their enthusiasm, stating, “I would highly recommend Elegant Image Limos for your next wine tour.”

Locally Owned with a Legacy of Excellence

Founded in 1998, Elegant Image Limos has remained committed to exceptional service throughout its history. Under new ownership since 2014, the company continues to grow and refine its offerings under the leadership of CEO Derek Stafford, who brings nearly two decades of industry experience.

With a reputation built on five-star service and unmatched attention to detail, Elegant Image Limos sets a new standard in transportation for the Paso Robles area. Whether for bachelorette parties, weddings, or custom wine tours, the company ensures every guest is treated as a VIP from start to finish.

For more information on Paso Robles Wine Tours by Elegant Image Limos, visit Paso Robles Wine Tours.

About Elegant Image Limos

Elegant Image Limos is a Central Coast transportation company specializing in luxury wine tours across the Paso Robles region. Offering a fleet of limousines, party buses, and sedans, the company curates custom experiences for groups of all sizes. With a commitment to exceptional service and customer satisfaction, Elegant Image Limos transforms transportation into a key part of every wine tour adventure.

Media Contact
Company Name: Elegant Image Limos
Contact Person: Derek Stafford
Email: Send Email
Phone: (805) 772-5390
Country: United States
Website: https://www.elegantimagelimos.com/paso-robles-wine-tours

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Elegant Image Limos Elevates Paso Robles Wine Tours with Custom Luxury Experiences

Author Amanda Evans Debuts New Sci-Fi Romance Novel: Kheira & Khogee: The Legend Begins

A Cosmic Tale of Love, Memory, and Destiny Set to Captivate Readers.

SunGate Publishing is excited to announce the release of Kheira & Khogee: The Legend Begins, the latest novel by award-winning author Amanda Evans. This dialogue-driven sci-fi romance explores themes of love, memory, and destiny as two souls race against the odds to save their galaxy—and each other.

“This book is a labor of love, a blend of my passion for the cosmos and the complex emotions that tie us all together,” commented Evans. “I wanted to create a story that resonates with anyone who’s ever looked up at the stars and felt the stirrings of adventure and romance.”

In this gripping space adventure, twin flames Kheira and Khogee are on a mission to prevent galactic catastrophe. However, the stakes rise when Kheira experiences sudden memory loss, forgetting not only their mission but also her very identity and the bond she shares with Khogee. Determined to reignite their connection, Khogee embarks on a perilous journey to help Kheira remember their purpose and their love.

Throughout their voyage, the couple confronts dangers lurking at every corner. Their challenges extend beyond interstellar threats: assassins sent by their parents complicate matters further, forcing them to navigate betrayal and conflict while staying true to their mission. Will Kheira and Khogee overcome their trials and rediscover the love that binds them before it’s too late?

A reader shared, “I enjoyed every moment of reading Kheira & Khogee: The Legend Begins. It is such a beautiful love story.”

At its core, Kheira & Khogee isn’t just an action-packed space adventure; it’s an exploration of love that transcends time, memory, and betrayal. Amanda Evans has crafted a dialogue-driven novel, ensuring that the characters’ vibrant exchanges keep readers immersed from start to finish. The story combines heart-pounding adventure with heartfelt emotion, making it an unforgettable journey beyond the stars.

This exciting new release is available now, inviting readers to embark on a journey of love and adventure across the galaxy. Order on Amazon here.

About the Author

Amanda Evans began her literary career writing poetry, culminating in her first book, Thoughts in the Meantime. Now transitioning into the sci-fi/fantasy genre, Evans continues to engage readers with dynamic stories that explore personal growth and human connection. When not writing, she enjoys cultivating self-awareness and spending time with family and friends.

Media Contact
Company Name: SunGate Publishing LLC
Contact Person: Media Relations
Email: Send Email
Phone: 800-291-4571
Country: United States
Website: https://sungatepublishing.com

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Author Amanda Evans Debuts New Sci-Fi Romance Novel: Kheira & Khogee: The Legend Begins

Kingy AI Offers AI Companies the Opportunity to Elevate Sales and Visibility through Exclusive Marketing Collaborations

Growing firm empowers AI App creators with strategic marketing solutions to enhance growth and reach.

Kingy AI, a rising force leader in the AI promotion landscape, is pleased to announce its strategic support for companies developing innovative AI applications, tools, and platforms. By leveraging Kingy AI’s highly successful YouTube channel, boasting over 16 million views, and their expertise in information-rich blog posts, AI app creators can elevate their marketing efforts and achieve new levels of visibility and growth.

As the AI landscape becomes increasingly competitive, Kingy AI’s services cater to companies with outstanding products that require an extra boost in marketing or sales. The combination of engaging, high-quality video content and in-depth blog posts positions Kingy AI as a one-stop partner for maximizing the impact of cutting-edge AI solutions.

“We work with some of the best AI companies across the globe to highlight exceptional tools and platforms,” commented Curtis, co-founder of Kingy AI. “If you have an AI app that could benefit from professional marketing support, we can help you reach a larger audience and make a lasting impression.”

Kingy AI’s website and YouTube channel are increasingly well-known for breaking news about and spotlighting innovative technologies, helping companies stand out in an increasingly saturated market. The platform provides AI creators with a unique opportunity to showcase their products through expertly crafted videos, alongside comprehensive blog content that dives deep into the value and capabilities of the featured tools.

Some recent highlights from Kingy AI’s content include:

  • “Discover RouteLLM: The Smart Way to Use AI Models with ChatLLM”

  • “Unlock Creativity with Domo AI: Transform Your Videos and Images Effortlessly”

  • “AIvideo.com: Revolutionizing Video Creation with Artificial Intelligence”

These videos illustrate Kingy AI’s commitment to providing clear, engaging, and informative content that resonates with audiences across industries. The platform’s proven approach ensures that each collaboration is not only well-promoted but also insightful, offering genuine value to viewers and readers.

Companies interested in gaining more visibility and boosting sales through Kingy AI’s marketing and content services are encouraged to connect directly.

For more information visit https://kingy.ai.

About Kingy AI

Kingy AI specializes in promoting the latest and most innovative AI applications, tools, and platforms across various media channels. With a thriving YouTube channel and comprehensive content offerings, Kingy AI helps businesses elevate their presence and reach new audiences through expert video production and blog posts.

Media Contact
Company Name: Kingy AI
Contact Person: Curtis
Email: Send Email
Country: United States
Website: https://kingy.ai

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Kingy AI Offers AI Companies the Opportunity to Elevate Sales and Visibility through Exclusive Marketing Collaborations

The Hyperscale Data Center Market Investment to Hit $304.73 Bn by 2029, More than 10,249 MW Power Capacity to be Added in the Next 6 Years – Arizton

“Hyperscale Data Center Market Research Report by Arizton”
Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast 2024–2029.

According to Arizton’s latest research report, the hyperscale data center market is growing at a CAGR of 8.72% during 2023-2029.

       

Looking for More Information? Click: https://www.arizton.com/market-reports/hyperscale-data-center-market-report

 

Report Scope:       

Market Size – Investment (2029): $304.73 Billion           

Market Size – Investment (2023): $184.48 Billion           

CAGR – Investment (2023-2029): 8.27%   

Market Size: Area (2029): 53 Million Sq. Ft

Market Size: Power Capacity (2029): 10,249 MW      

Historic Year:  2020-2022               

Base Year: 2023               

Forecast Year: 2024-2029               

Market Segmentation: Infrastructure, IT Infrastructure, Electrical Infrastructure, Mechanical Infrastructure, Cooling Systems, Cooling Technique, General Construction, Tier Standards, and Geography

Geographical Analysis: North America, Latin America, Western Europe, Nordics, Central & Eastern Europe, Middle East, Africa, APAC, and Southeast Asia

       

Market Overview

In 2023, the global hyperscale data center market attracted over $184.48 billion in investments, propelled by significant contributions from leading hyperscale operators, including AWS, Microsoft, Google, Meta, Alibaba, Tencent, Apple, Equinix, Digital Realty, Vantage Data Centers, CyrusOne, and NTT DATA.

The U.S. hyperscale data center market is experiencing notable growth, fueled by several factors such as increased internet usage, social media penetration, availability of free cooling and renewable energy, and the adoption of cloud-based services, along with various tax incentives.

Key players like Meta, Microsoft, AWS, and Google are further enhancing market dynamics with their investments, focusing on expanding their global presence in emerging markets across Europe and the Asia-Pacific region. In 2023, North America led the investment landscape with approximately $85.74 billion, followed by the Asia-Pacific region at $59.54 billion, Europe (including Western Europe, the Nordics, and Central & Eastern Europe) at $31.39 billion, the Middle East and Africa at $4.56 billion, and Latin America at $3.25 billion.

Additionally, other major cloud operators, such as Alibaba Cloud, Tencent Cloud, Oracle, IBM Cloud, and OVHcloud, are actively expanding their global footprints by developing multiple cloud regions, further driving investment in hyperscale data centers.

 

Key Trends

Data centers in the US are experiencing rapid growth, with many large hyperscale facility being built. This expansion is likely to result in higher energy consumption and carbon emission. To mitigate this impact, many data center companies are investing in clean renewable energy to power both their existing and upcoming facilities, helping to minimize their environmental footprint.

Data center automation solutions can identify the maintenance requirements of generator systems to avoid operational & backup power failures during outages. The regular maintenance of generators over a period of time is important since the diesel inside these systems can become polluted and subsequently affect the proper function of these systems. .

In the US, big investments in hyperscale data centers are anticipated to increase year after year. Hyperscale providers are shifting their focus toward the setting up of numerous edge locations, driven by the rollout of 5G technology.

 

Geographical Analysis

The global hyperscale data center market is predominantly led by the Americas, which encompass both North America and Latin America, holding approximately 48% of the total market share. Within this region, North America accounts for the highest investment, followed by Latin America. Europe ranks as the third-largest hyperscale data center market, with Western Europe leading in investments, followed by the Nordics and Central & Eastern Europe. In the Middle East and Africa, Saudi Arabia takes the lead in hyperscale data center investments, followed by South Africa, the UAE, Israel, and other countries. The Asia-Pacific (APAC) region stands as the second-largest market globally, with China dominating this area, capturing around 48% of the market share, followed by Japan, Australia, India, Indonesia, Hong Kong, Malaysia, and other APAC nations.

Looking for More Information? Click: https://www.arizton.com/market-reports/hyperscale-data-center-market-report

 

The Report Includes the Investment in the Following Areas:

 

Segmentation by Infrastructure

  • IT Infrastructure
  • Electrical Infrastructure
  • Mechanical Infrastructure
  • General Construction

 

Segmentation by IT Infrastructure

  • Server Infrastructure
  • Storage Infrastructure
  • Network Infrastructure

 

Segmentation by Electrical Infrastructure

  • UPS Systems
  • Generators
  • Transfer Switches & Switchgear
  • PDUs
  • Other Electrical Infrastructure

 

Segmentation by Mechanical Infrastructure

  • Cooling Systems
  • Racks
  • Other Mechanical Infrastructure

 

Segmentation by Cooling System

  • CRAC & CRAH Units
  • Chiller Units
  • Cooling Towers, Condensers & Dry Coolers
  • Economizers & Evaporative Coolers
  • Other Cooling Units

 

Segmentation by Cooling Technique

  • Air-based
  • Liquid-based

 

Segmentation by General Construction

  • Core & Shell Development
  • Installation & Commissioning Services
  • Engineering & Building Design
  • Fire Detection & Suppression
  • Physical Security
  • DCIM/BMS Solutions

 

Segmentation by Tier Standards

  • Tier I & Tier II
  • Tier III
  • Tier IV

 

Segmentation by Geography

  • North America
    • The U.S.
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Chile
  • Western Europe
  • The U.K.
  • Germany
  • France
  • Netherlands
  • Ireland
  • Spain
  • Other Western European Countries
  • Singapore
  • Indonesia
  • Malaysia
  • Thailand
  • Philippines
  • Vietnam
  • Nordics
    • Denmark
    • Sweden
    • Norway
    • Finland
  • Central & Eastern Europe
    • Poland
    • Other Central & Eastern European Countries
  • Middle East
    • UAE
    • Saudi Arabia
    • Israel
  • Africa
    • South Africa
    • Other African Countries
  • APAC
    • China
    • Hong Kong
    • Australia
    • New Zealand
    • Japan
    • India
    • South Korea
    • Taiwan
  • Southeast Asia

 

Vendors Landscape

IT Infrastructure Providers

  • Arista Networks
  • Atos
  • Broadcom
  • Cisco Systems
  • Dell Technologies
  • Extreme Networks
  • Fujitsu
  • Hewlett Packard Enterprise (HPE)
  • Hitachi Vantara
  • Huawei Technologies
  • IBM
  • Inspur
  • Inventec
  • Micron Technology
  • MiTAC Holdings
  • NetApp
  • Nimbus Data
  • Nexsan (StorCentric)
  • Oracle
  • Pure Storage
  • Pivot3
  • Quanta Cloud Technology(QCT )
  • Seagate Technology
  • Supermicro
  • Synology
  • Toshiba
  • Western Digital
  • Wiwynn

 

Support Infrastructure Providers

  • 3M
  • ABB
  • Airedale
  • Alfa Laval
  • Asetek
  • Assa Abloy
  • Bloom Energy
  • Carrier
  • Caterpillar
  • Cummins
  • Condair
  • Cormant
  • Cyber Power Systems
  • Daikin Applied
  • Delta Electronics
  • Eaton
  • Enlogic
  • FNT Software
  • Generac Power Systems
  • Green Revolution Cooling (GRC)
  • HITEC Power Protection
  • Honeywell International
  • Johnson Controls
  • Kohler Energy
  • KyotoCooling
  • Legrand
  • Mitsubishi Electric
  • Munters
  • Natron Energy
  • NetZoom
  • Nlyte Software
  • Panduit
  • Piller Power Systems
  • Riello Elettronica
  • Rolls-Royce
  • Schneider Electric
  • Siemens
  • STULZ
  • Trane
  • TrippLite (Eaton)
  • Vertiv
  • Yanmar
  • ZincFive

 

Construction Contractors & Subcontractors

  • AECOM
  • Bouygues Construction
  • DPR Construction
  • Holder Construction
  • Jacobs
  • M+W Group
  • Mercury
  • Arup
  • AtkinsRéalis
  • Aurecon
  • BENTHEM CROUWEL ARCHITECTS
  • CAP INGELEC
  • Corgan
  • Dar
  • Deerns
  • DSCO Group
  • Edarat Group
  • Fluor Corporation
  • Fortis Construction
  • Gensler
  • Gilbane Building Company
  • HDR
  • ISG
  • Kirby Group Engineering
  • KKCG
  • Laing O’Rourke
  • Larsen & Toubro
  • Linesight
  • Mace
  • Morrison Hershfield
  • Mortenson
  • NTT Facilities
  • RED Engineering
  • Royal HaskoningDHV
  • Sterling and Wilson
  • STO Building Group
  • Syska Hennessy Group
  • Turner Construction Company
  • Winthrop Technologies

 

Data Center Investors

  • Apple
  • AWS (Amazon Web Services)
  • CyrusOne
  • Digital Realty
  • Equinix
  • Facebook (Meta)
  • Google
  • Keppel Data Centres
  • Microsoft
  • NTT DATA
  • ST Telemedia Global Data Centres
  • Vantage Data Centers
  • VNET GrouP
  • Africa Data Centres
  • Nxtra by Airtel
  • AirTrunk Operating
  • Aligned Data Centers
  • atNorth
  • Beyond.pl
  • Big Data Exchange
  • Bridge Data Centres
  • CDC Data Centres
  • Chindata Group
  • CloudHQ
  • ClusterPower
  • Cologix
  • Compass Datacenters
  • CoreSite
  • DataBank
  • Data4 Group
  • EdgeConneX
  • Etisalat
  • Flexential
  • GDS Services
  • Global Switch
  • Green Mountain AS – Data centres
  • Gulf Data Hub
  • HostDime
  • InterNexa
  • Iron Mountain
  • iXAfrica Data Centres
  • IXcellerate
  • Moro Hub
  • NEXTDC
  • ODATA
  • Ooredoo Group
  • Orange Business
  • Paratus Namibia
  • QTS Data Centers
  • Raxio Data Centres
  • Rostelecom Data Centres
  • Scala Data Centers
  • Sify Technologies
  • SUNeVision
  • Telecom Egypt
  • T5 Data Centers
  • Turkcell
  • wingu.africa
  • Yondr
  • Yotta Infrastructure.
  • AdaniConneX
  • KEVLINX
  • Novva Data Centers
  • Data First
  • Khazna Data Centers
  • Mobily
  • Open Access Data Centres (OADC)
  • center3

 

New Entrants

  • Ada Infrastructure
  • Corscale Data Centers
  • Crane Data Centers
  • DHAmericas
  • Edged
  • Layer 9 Data Centers.
  • Quantum Loophole
  • NE Edge
  • Rowan Digital Infrastructure

 

In a nutshell, the Arizton Advisory & Intelligence market research report provides valuable market insights for industry stakeholders, investors, researchers, consultants, and business strategists aiming to gain a thorough understanding of the hyperscale data center market. Request for Free Sample to get a glance of the report now:

https://www.arizton.com/market-reports/hyperscale-data-center-market-report

 

What Key Findings Will Our Research Analysis Reveal?     

How big is the global hyperscale data center market?

What is the estimated market size in terms of area in the global hyperscale data center market by 2029?

Which region holds the most significant global hyperscale data center market share?

What is the growth rate of the global hyperscale data center market?

How many MW of power capacity is expected to reach the global hyperscale data center market by 2029?

 

Looking for Customization According to Your Business Requirement? https://www.arizton.com/customize-report/4575

  

Other Related Reports that Might be of Your Business Requirement     

Global Data Center UPS Market Landscape 2024-2029

https://www.arizton.com/market-reports/data-center-ups-market-2025

 

Why Arizton?                                                

100% Customer Satisfaction                                                

24×7 availability – we are always there when you need us                                                

200+ Fortune 500 Companies trust Arizton’s report                                                

80% of our reports are exclusive and first in the industry                                                

100% more data and analysis                                                

1500+ reports published till date                              

                   

Post-Purchase Benefit                                            

  • 1hr of free analyst discussion                                            
  • 10% off on customization                         

                  

About Us:                                                                                     

Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services.                                                                                   

We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.                                                                                    

Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.                                                                                         

Media Contact
Company Name: Arizton Advisory & Intelligence
Contact Person: Jessica
Email: Send Email
Phone: +1 3122332770
Country: United States
Website: https://www.arizton.com/market-reports/hyperscale-data-center-market-report

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: The Hyperscale Data Center Market Investment to Hit $304.73 Bn by 2029, More than 10,249 MW Power Capacity to be Added in the Next 6 Years – Arizton

Over 106 New Facilities to Reshape Southeast Asia Data Center Market – Arizton Analysis

“SOUTHEAST ASIA DATA CENTER PORTFOLIO”
Malaysia dominates Southeast Asia’s upcoming data center market with almost 50% of the total power capacity.

Arizton has released its latest research report on the Southeast Asia data center portfolio, which includes analyses of 239 existing data centers and 106 upcoming data centers.

Malaysia is the leader in Southeast Asia’s upcoming data center market, accounting for nearly 50% of the total power capacity. Airtrunk stands as the largest data center operator in the region, followed by Princeton Digital Group and ST Telemedia Global Data Centers. The projected upcoming data center capacity in Southeast Asia exceeds 4.5 GW at full build, which is more than double the region’s current capacity. Currently, almost 80% of the existing rack capacity is concentrated in Singapore, Malaysia, and Indonesia, while emerging data center locations include Thailand and Vietnam.

This Excel-based database product provides a comprehensive portfolio analysis of the Southeast Asia (SEA) data center market, focusing on colocation data centers. It includes detailed analyses of 239 existing data centers and 106 upcoming data centers across several countries, including Indonesia, Malaysia, Philippines, Singapore, Thailand, and Vietnam. The database offers insights into existing and upcoming white-floor space measured in square feet, current IT load capacity for 2024, and projected capacity additions from 2025 to 2028. Additionally, it features retail colocation pricing for various rack sizes, including Quarter Rack (1/4), Half Rack Cabinets (1/2), and Full Rack Cabinets (42U/45U/47U), along with wholesale colocation pricing per kW.

 

UPCOMING DATA CENTERS (106 Facilities)

  • Investment Snapshot
  • Location (Region/Country/City)
  • Investor Name
  • Area (White-Floor Area)
  • Power Capacity (IT Load Capacity)
  • Investment ($ Million)
  • Electrical Infrastructure Investment ($ Million)
  • Mechanical Infrastructure Investment ($ Million)
  • General Construction Services Investment ($ Million)
  • Announcement Year
  • Project Status (Under Construction/Announced & Planned)
  • Active or Expected Year of Opening

 

Looking for More Information? Click: https://www.arizton.com/market-reports/southeast-asia-data-center-market-facilities

       

Other Related Reports that Might be of Your Business Requirement    

Portugal Existing & Upcoming Data Center Portfolio

https://www.arizton.com/market-reports/portugal-data-center-portfolio

Oceania Existing & Upcoming Data Center Portfolio

https://www.arizton.com/market-reports/oceania-data-center-market-report

Malaysia Existing & Upcoming Data Center Portfolio

https://www.arizton.com/market-reports/malaysia-data-center-portfolio

 

Why Arizton?                                               

100% Customer Satisfaction                                               

24×7 availability – we are always there when you need us                                               

200+ Fortune 500 Companies trust Arizton’s report                                               

80% of our reports are exclusive and first in the industry                                               

100% more data and analysis                                               

1500+ reports published till date                             

                  

Post-Purchase Benefit                                           

  • 1hr of free analyst discussion                                           
  • 10% off on customization                        

                 

About Us:                                                                                    

Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services.                                                                                  

We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.                                                                                   

Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.                                                                                        

Media Contact
Company Name: Arizton Advisory & Intelligence
Contact Person: Jessica
Email: Send Email
Phone: +1 3122332770
Country: United States
Website: https://www.arizton.com/market-reports/southeast-asia-data-center-market-facilities

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Over 106 New Facilities to Reshape Southeast Asia Data Center Market – Arizton Analysis

Exocrine Pancreatic Insufficiency Treatment Market Size, Drugs, Emerging Therapies and Companies 2034 | DelveInsight

DelveInsight’s “Exocrine Pancreatic Insufficiency Market Insight, Epidemiology, and Market Forecast – 2034” report delivers an in-depth understanding of exocrine pancreatic insufficiency, historical and forecasted epidemiology as well as the exocrine pancreatic insufficiency market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.

 

Explore the intricate details of the Exocrine Pancreatic Insufficiency Market: Uncover drug uptake, treatment dynamics, and epidemiological trends with our comprehensive Exocrine Pancreatic Insufficiency Market Forecast. Click here to stay ahead in healthcare innovation @ Exocrine Pancreatic Insufficiency Market Size

 

Key Takeaways from the Exocrine Pancreatic Insufficiency Market Report

  • In September 2024:- Société des Produits Nestlé (SPN)- A 3-part, Phase 1a/1b, First-in-human, Randomized, Double-blind, Placebo-controlled Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of Oral CDX-7108 in Healthy Adult Subjects and to Evaluate Proof-of-concept Via Pharmacodynamics of a Single Dose of Oral CDX-7108 in Subjects with Exocrine Pancreatic Insufficiency.
  • In September 2024:- Entero Therapeutics- This is an Phase 2, open label, single arm pilot study assessing the safety and efficacy of adrulipase in an enteric microgranule formulation. Patients with a confirmed diagnosis of cystic fibrosis who are 18 years of age or greater will be screened for eligibility if they have been clinically controlled on a stable dose of commercial pancreatic enzyme replacement therapy (PERT) for at least one month. Patients on cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapies must have been on a stable dose for at least 3 months prior to study entry, and no dose changes will be made during the study.
  • According to a study conducted by Nieto et al. (2016), several prevalence studies and the relation of EPI in both types of diabetes show a wide range, being higher in Type I diabetes with a prevalence of 25–74% versus a 28– 54% in type II diabetics.
  • According to Jiuang et al. (2023), the prevalence of EPI in newly diagnosed Crohn’s Disease (CD) patients ranges from 10.5% to 46.5%, with a pooled prevalence of 26.2% (95% CI 8.43–43.92%). In CD patients on a gluten-free diet (GFD), the rate of EPI ranges from 1.9% to 18.2%.
  • The total diagnosed prevalent cases of EPI in the US in 2023 were found to be highest among the 7MM.
  • About ~80% of patients suffering from Cystic Fibrosis and Schwachman–Diamond Syndrom developed EPI in the US in the year 2023.
  • In the United States the causative indication accounting for the highest cases of EPI were Celiac disease and Type II diabetes comprising about ~2,419,000 and ~32,205,000 cases respectively among the other causative diseases like Mild Acute Pancreatitis, Moderate to Severe Acute Pancreatitis Chronic Pancreatitis, Celiac Disease, Cystic Fibrosis, Crohn’s Disease, Diabetes (Type I and II) and others
  • The leading Exocrine Pancreatic Insufficiency Companies such as AbbVie, Nestle, Digestive Care, Inc., AzurRx BioPharma, Inc., Abbott, Orlando Health, Inc., Chiesi Farmaceutici, and many others.
  • Promising Exocrine Pancreatic Insufficiency Therapies such as PERTZYE (pancrelipase), CREON (pancrelipase)/LIPACREON, ZENPEP (pancrelipase), .PANCREAZE (pancrelipase), VIOKACE (pancrelipase), and others.

 

Delve deep into the Exocrine Pancreatic Insufficiency Market Landscape: Analyze drug adoption, treatment paradigms, and epidemiological shifts in our detailed Exocrine Pancreatic Insufficiency Market Forecast. Click here to shape the future @ Exocrine Pancreatic Insufficiency Epidemiology Insights

 

Exocrine Pancreatic Insufficiency Overview

Exocrine pancreatic insufficiency (EPI) is a condition caused by reduced or inappropriate secretion or activity of pancreatic juice and its digestive enzymes, pancreatic lipase in particular. EPI can result in clinical manifestation such as steatorrhea, weight loss, and biochemical alterations related to lipids and liposoluble micronutrients malabsorption and maldigestion.

 

Exocrine Pancreatic Insufficiency Epidemiology Insights

  • Exocrine Pancreatic Insufficiency Prevalence in the US
  • Exocrine Pancreatic Insufficiency Prevalence of Causative Indications
  • Exocrine Pancreatic Insufficiency Diagnosed and Treatable Cases

 

Navigate the complexities of the Exocrine Pancreatic Insufficiency Market: Gain insights into drug trends, treatment scenarios, and epidemiological data through our insightful Exocrine Pancreatic Insufficiency Market Forecast. Click here to get more insights @ Exocrine Pancreatic Insufficiency Treatment Market

 

Exocrine Pancreatic Insufficiency Treatment Market Landscape

The Exocrine Pancreatic Insufficiency treatment primarily focuses on supplementing the deficient pancreatic enzymes and managing the underlying causes to improve digestion and nutrient absorption. Effective management of EPI involves a combination of enzyme replacement therapy, dietary modifications, addressing underlying causes, and lifestyle changes. These treatments aim to improve digestive function, enhance nutrient absorption, and alleviate symptoms to improve the patient’s quality of life.

 

Exocrine Pancreatic Insufficiency Market Factors

Key factors contributing to the positive Exocrine Pancreatic Insufficiency market growth include the increasing prevalence of conditions like cystic fibrosis and chronic pancreatitis, advancements in pancreatic enzyme replacement therapy (PERT), and rising awareness and early diagnosis of EPI. Additionally, an aging population and increased healthcare expenditure enhance market demand. Regulatory approvals and investment in research and development also drive Exocrine Pancreatic Insufficiency market growth.

 

Unlock insights into the Exocrine Pancreatic Insufficiency Market: discover drug uptake patterns, treatment landscapes, and epidemiological insights with our exclusive Exocrine Pancreatic Insufficiency Market Forecast. Click here @ Exocrine Pancreatic Insufficiency Market Drivers and Barriers

 

Exocrine Pancreatic Insufficiency Marketed Drugs

 

  • PERTZYE: Digestive Care

PERTZYE is a pancreatic enzyme preparation consisting of pancrelipase, an extract derived from porcine pancreatic glands. Pancrelipase contains multiple enzyme classes, including porcine-derived lipases, proteases, and amylases. In July 2012, PERTZYE was approved by the US FDA in patients with exocrine pancreatic insufficiency due to cystic fibrosis or other conditions. Further, in October 2016, the drug received FDA approval for an infant-specific dose of PERTZYE in a 4,000 USP lipase units capsule. The new capsule strength will enable guideline-recommended dosing and administration of PERTZYE for infants (up to 12 months) with exocrine pancreatic insufficiency.

 

  • CREON: Solvay Pharmaceuticals

It is a pancreatic enzyme preparation consisting of a combination of lipases, proteases, and amylases and is an extract derived from porcine pancreatic glands. In May 2013, CREON received the US FDA approval for the commercial availability of a new, higher-dose variant of CREON delayed-release capsules to treat patients with EPI due to cystic fibrosis, swelling of the pancreas that lasts a long time (chronic pancreatitis), removal of some or all of the pancreas (pancreatectomy), or other conditions. In April 2011, CREON was approved in Japan under the brand name LIPACREON.

 

Exocrine Pancreatic Insufficiency Emerging Drugs

 

  • FW-EPI (adrulipase): First Wave Biopharma

FW-EPI is a recombinant lipase enzyme administered as an oral, non-systemic biologic capsule for the treatment of exocrine pancreatic insufficiency associated with cystic fibrosis and chronic pancreatitis. It is derived from the Yarrowia lipolytica yeast lipase and is designed to break up fat molecules in the digestive tract of exocrine pancreatic insufficiency patients so that they can be absorbed as nutrients. In developing adrulipase, First Wave is seeking to provide cystic fibrosis and chronic pancreatitis patients with a safe and effective therapy to control exocrine pancreatic insufficiency that is non-animal derived, offers the potential to dramatically reduce their daily pill burden, and can be manufactured on demand at high volumes safely and with a high degree of reproducibility. First Wave is developing adrulipase as a monotherapy and in combination with PERT.

 

  • ANG003: Anagram Therapeutics

ANG003 is a novel broadspectrum orally delivered enzyme replacement therapy for the treatment of malabsorption and exocrine pancreatic insufficiency. The drug is currently in Phase I trial for adult subjects with CF-related EPI.

 

Exocrine Pancreatic Insufficiency Market Outlook

The treatment landscape of exocrine pancreatic insufficiency majorly includes pancreatic enzyme replacement therapy, lifestyle modifications (e.g., avoidance of fatty foods, limitation of alcohol intake, cessation of smoking, and consumption of a well-balanced diet), and vitamin supplementation (primarily the fat-soluble vitamins A, D, E, and K). PERT is the first-line therapeutic mainstay that is prescribed to patients.

The pancreatic enzyme products used for PERT are extracts of porcine pancreas that contain all three pancreatic enzymes (i.e., amylase, protease, and lipase) in varying proportions. However, it is lipase that plays a paramount role in therapy. Pharmacological therapies are the mainstay treatment option followed by patients with exocrine pancreatic insufficiency. The market of exocrine pancreatic insufficiency includes the use of the drugs either as monotherapy and are not interchangeable. There are several approved drugs in the market of different classes. The following PEPs have been approved by the FDA for the treatment of maldigestion in patients whose bodies do not produce sufficient pancreatic enzymes: CREON, PANCREAZE, PERTZYE, VIOKACE, and ZENPEP. Some medicines are needed to treat pain.

 

Scope of the Exocrine Pancreatic Insufficiency Market Report

  • Coverage- 7MM
  • Exocrine Pancreatic Insufficiency Companies- AbbVie, Nestle, Digestive Care, Inc., AzurRx BioPharma, Inc., Abbott, Orlando Health, Inc., Chiesi Farmaceutici, and many others.
  • Exocrine Pancreatic Insufficiency Therapies- PERTZYE (pancrelipase), CREON (pancrelipase)/LIPACREON, ZENPEP (pancrelipase), .PANCREAZE (pancrelipase), VIOKACE (pancrelipase), and others.
  • Exocrine Pancreatic Insufficiency Market Dynamics: Exocrine Pancreatic Insufficiency Market drivers and Exocrine Pancreatic Insufficiency Market Barriers
  • Exocrine Pancreatic Insufficiency Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
  • Exocrine Pancreatic Insufficiency Unmet Needs, KOL’s views, Analyst’s views, Exocrine Pancreatic Insufficiency Market Access and Reimbursement

 

Gain a strategic edge in the Exocrine Pancreatic Insufficiency Market: explore comprehensive drug insights, treatment updates, and epidemiological forecasts in our in-depth Exocrine Pancreatic Insufficiency Market Forecast. Click here to lead in advancements @ Exocrine Pancreatic Insufficiency Clinical Trials Assessment

 

Table of Content

1. Key Insights

2. Report Introduction

3. Executive Summary

4. Exocrine Pancreatic Insufficiency (EPI) Market Overview at a Glance

5. Key Events

6. Epidemiology and Market Forecast Methodology

7. Disease Background and Overview

8. Epidemiology and Patient Population

9. Patient Journey

10. Marketed Products

11. Emerging Therapies

12 Exocrine Pancreatic Insufficiency: Seven Major Market Analysis

13. Unmet Needs

14. SWOT Analysis

15. KOL Views

16. Market Access and Reimbursement

17. Appendix

18. DelveInsight Capabilities

19. Disclaimer

 

About DelveInsight

DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Exocrine Pancreatic Insufficiency Treatment Market Size, Drugs, Emerging Therapies and Companies 2034 | DelveInsight

Psoriasis Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers

DelveInsight’s, “Psoriasis Pipeline Insight 2024” report provides comprehensive insights about 80+ companies and 80+ pipeline drugs in Psoriasis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

 

Explore our latest breakthroughs in Psoriasis Research. Learn more about our innovative pipeline today! @ Psoriasis Pipeline Outlook

 

Key Takeaways from the Psoriasis Pipeline Report

  • In October 2024:- Xantho Biotechnology Co., Ltd- This trial is a Phase IIa clinical trial. Around 65 subjects will be enrolled into this study to primarily assess the treatment efficacy of 5% GM-XANTHO in patients with psoriasis, as well as the safety and tolerability of 5% GM-XANTHO. Two third of the total subjects will be given the investigational product, 5% GM-XANTHO, and the other third will take placebo. The treatment period will last for 28 consecutive days, followed by a safety follow-up for 2 weeks. During the study, there will be 8 scheduled visits to the clinical center.
  • In October 2024:- Bristol-Myers Squibb- A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Effect of Deucravacitinib on Quality of Life in Participants With Plaque Psoriasis in a Community Setting. The purpose of this study is to evaluate the effect of deucravacitinib on quality of life (QoL) in participants with plaque psoriasis in a community setting.
  • In October 2024:- Sanofi- This is a Phase 2, international, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, 12-week study. It is designed to assess the therapeutic dose, efficacy, and safety of treatment with SAR441566 in male and female adults with moderate to severe plaque psoriasis. Study details include a screening period (4 weeks and not less than 11 days before Day 1), a treatment period (12 weeks ± 3 days) and a post-treatment period (safety follow-up) (4 weeks ± 3 days). The total number of study visits will be 7.
  • In October 2024;- AbbVie- The study will be broken up into 2 sub-studies by disease location, participants with moderate to severe genital psoriasis (Study G) and moderate to severe scalp psoriasis (Study S). In both sub-studies participants will receive subcutaneous (SC) injections of risankizumab during the 52 week treatment period, or SC injections of placebo risankizumab during the 16 week treatment period followed by SC injections of risankizumab during the 36 week treatment period, with an 8-week follow-up period after the 52 week treatment period.
  • DelveInsight’s Psoriasis pipeline report depicts a robust space with 80+ active players working to develop 80+ pipeline therapies for Psoriasis treatment.
  • The leading Psoriasis Companies such as Mylan, Biocad, Bristol-Myers Squibb, Celltrion, Coherus BioSciences, Janssen Pharmaceuticals, Can-Fite Biopharma, Arcutis Biotherapeutics, Amgen, Iltoo Pharma, GlaxoSmithKline, Galectin Therapeutics, Evelo Biosciences, Galderma, BioMimetix JV, Menlo Therapeutics Inc., Aristea Therapeutics, UNION Therapeutics, MetrioPharm, Sienna Biopharmaceuticals, and others.
  • Promising Psoriasis Therapies such as Hypericin, AX-158, Deucravacitinib, CMAB015, Secukinumab, Rimegepant, IBI112, BMS-986165, and others.

 

Stay informed about the cutting-edge advancements in Psoriasis treatments. Download for updates and be a part of the revolution in care @ Psoriasis Clinical Trials Assessment

 

Psoriasis Emerging Drugs Profile

  • Topical roflumilast: Arcutis Biotherapeutics

Topical roflumilast cream (ARQ-151) is a small molecule inhibitor of phosphodiesterase type 4 (PDE4), an intracellular enzyme that increases the production of proinflammatory mediators and decreases production of anti-inflammatory mediators, and has been implicated in a wide range of inflammatory diseases including psoriasis, eczema, and chronic obstructive pulmonary disease (COPD). The therapy is in Phase III clinical development for the treatment of Plaque Psoriasis.

  • GSK2982772: GlaxoSmithKline

GSK2982772 is an ATP competitive receptor-interacting protein-1 (RIP1) kinase (RIPK1) inhibitor with the IC50 value of 16 nM. GSK2982772 potently binds to RIP1 with exquisite kinase specificity and has excellent activity in blocking many TNF-dependent cellular responses. RIP1 has emerged as an important upstream kinase that has been shown to regulate inflammation through both scaffolding and kinase specific functions. The molecule is in Phase I clinical development for the treatment of Psoriasis.

 

Learn more about Psoriasis Drugs opportunities in our groundbreaking Psoriasis Research and development projects @ Psoriasis Unmet Needs

 

Psoriasis Companies

Mylan, Biocad, Bristol-Myers Squibb, Celltrion, Coherus BioSciences, Janssen Pharmaceuticals, Can-Fite Biopharma, Arcutis Biotherapeutics, Amgen, Iltoo Pharma, GlaxoSmithKline, Galectin Therapeutics, Evelo Biosciences, Galderma, BioMimetix JV, Menlo Therapeutics Inc., Aristea Therapeutics, UNION Therapeutics, MetrioPharm, Sienna Biopharmaceuticals, and others.

 

Psoriasis pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as

  • Oral
  • Parenteral
  • Intravitreal
  • Subretinal
  • Topical.
  • Molecule Type

 

Psoriasis Products have been categorized under various Molecule types such as

  • Monoclonal Antibody
  • Peptides
  • Polymer
  • Small molecule
  • Gene therapy
  • Product Type

 

Discover the latest advancements in Psoriasis treatment by visiting our website. Stay informed about how we’re transforming the future of disease @ Psoriasis Market Drivers and Barriers, and Future Perspectives

 

Scope of the Psoriasis Pipeline Report

  • Coverage- Global
  • Psoriasis Companies- Mylan, Biocad, Bristol-Myers Squibb, Celltrion, Coherus BioSciences, Janssen Pharmaceuticals, Can-Fite Biopharma, Arcutis Biotherapeutics, Amgen, Iltoo Pharma, GlaxoSmithKline, Galectin Therapeutics, Evelo Biosciences, Galderma, BioMimetix JV, Menlo Therapeutics Inc., Aristea Therapeutics, UNION Therapeutics, MetrioPharm, Sienna Biopharmaceuticals, and others.
  • Psoriasis Therapies- Hypericin, AX-158, Deucravacitinib, CMAB015, Secukinumab, Rimegepant, IBI112, BMS-986165, and others.
  • Psoriasis Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
  • Psoriasis Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III

 

For a detailed overview of our latest research findings and future plans, read the full details of Psoriasis Pipeline on our website @ Psoriasis Emerging Drugs and Companies

 

Table of Content

  1. Introduction
  2. Executive Summary
  3. Psoriasis: Overview
  4. Pipeline Therapeutics
  5. Therapeutic Assessment
  6. Psoriasis – DelveInsight’s Analytical Perspective
  7. In-depth Commercial Assessment
  8. Psoriasis Collaboration Deals
  9. Late Stage Products (Phase III)
  10. CT-P43: Celltrion
  11. Drug profiles in the detailed report…..
  12. Mid Stage Products (Phase II)
  13. EDP1815: Evelo Biosciences
  14. Drug profiles in the detailed report…..
  15. Early Stage Products (Phase I)
  16. AZD0284: AstraZeneca
  17. Drug profiles in the detailed report…..
  18. Early Stage Products (Preclinical)
  19. AZD0284: AstraZeneca
  20. Drug profiles in the detailed report…..
  21. Inactive Products
  22. Psoriasis Key Companies
  23. Psoriasis Key Products
  24. Psoriasis- Unmet Needs
  25. Psoriasis- Market Drivers and Barriers
  26. Psoriasis- Future Perspectives and Conclusion
  27. Psoriasis Analyst Views
  28. Psoriasis Key Companies
  29. Appendix

  

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Psoriasis Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers